Ethical considerations surrounding survival benefit-based liver allocation

Liver Transplantation

Volumn 20, Issue 2, 2014, Pages 140-146

  Keller, Eric J ^a   Kwo, Paul Y ^a   Helft, Paul R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BIOETHICS; DONOR; DONOR SELECTION; END STAGE LIVER DISEASE; GRAFT RECIPIENT; HUMAN; INFORMED CONSENT; LIVER TRANSPLANTATION; PATIENT AUTONOMY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVAL RATE;

AGE FACTORS; ALGORITHMS; END STAGE LIVER DISEASE; ETHICS, MEDICAL; GEOGRAPHY; HUMANS; LIVER TRANSPLANTATION; MODELS, STATISTICAL; QUALITY OF LIFE; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WAITING LISTS;

EID: 84893194132     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23780     Document Type: Review

References (47)

1. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, Merion RM,. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009; 9 (pt 2): 970-981.
2. Liver and Intestinal Organ Transplantation Committee. Interim report. http://optn.transplant.hrsa.gov/Committee Reports/interim-main- Liver&IntestinalOrganTransplantation Committee-4-12-2013-14-17.pdf. Published March 13, 2013. Accessed October 2013.
3. OPTN/UNOS Liver and Intestinal Organ Transplantation Committee. Concept document: next steps toward improving liver distribution. http://optn. transplant.hrsa. gov/SharedContentDocuments/LiverConcept-123010.pdf. Published January 4, 2001. Accessed October 2013.
4. Perera MT, Mirza DF, Elias E,. Liver transplantation: issues for the next 20 years. J Gastroenterol Hepatol 2009; 24 (suppl 3): S124-S131.
5. Organ Procurement and Transplantation Network. http://optn.transplant. hrsa.gov. Accessed February 2013.
6. Bonney GK, Aldersley MA, Asthana S, Toogood GJ, Pollard SG, Lodge JP, Prasad KR,. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation 2009; 87: 1858-1863.
7. Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ,. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation 2005; 80: 145-148.
8. Moore DE, Feurer ID, Speroff T, Gorden DL, Wright JK, Chari RS, Pinson CW,. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005; 140: 273-277.
9. Nardo B, Masetti M, Urbani L, Caraceni P, Montalti R, Filipponi F, et al. Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant 2004; 4: 1139-1147.
10. Schemmer P, Nickkholgh A, Hinz U, Gerling T, Mehrabi A, Sauer P, et al. Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis. Transplant Proc 2007; 39: 529-534.
11. Amin MG, Wolf MP, TenBrook JA Jr, Freeman RB Jr, Cheng SJ, Pratt DS, Wong JB,. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004; 10: 1468-1475.
12. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM,. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419-425.
13. Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006; 244: 439-450.
14. Fridell JA, Mangus RS, Hollinger EF, Milgrom ML, Taber TE, Mohler E, et al. No difference in transplant outcomes for local and import pancreas allografts. Transplantation 2009; 88: 723-728.
15. Gastaca M,. Extended criteria donors in liver transplantation: adapting donor quality and recipient. Transplant Proc 2009; 41: 975-979.
16. Nickkholgh A, Weitz J, Encke J, Sauer P, Mehrabi A, Büchler MW, et al. Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature. Nephrol Dial Transplant 2007; 22 (suppl 8): viii29-viii36.
17. Cronin DC II, Millis JM,. Living donor liver transplantation: the ethics and the practice. Hepatology 2008; 47: 11-13.
18. Miller CM, Smith ML, Diago Uso T,. Living donor liver transplantation: ethical considerations. Mt Sinai J Med 2012; 79: 214-222.
19. Siparsky N, Axelrod D, Freeman RB,. Organ allocation in liver transplantation: ethics, organ supply, and evidence-based practice. In:, Clavien PA, Trotter JF, eds. Medical Care of the Liver Transplant Patient. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2012: 75-87.
20. Freeman RB, Jamieson N, Schaubel DE, Porte RJ, Villamil FG,. Who should get a liver graft? J Hepatol 2009; 50: 664-673.
21. Merion RM, Sharma P, Mathur AK, Schaubel DE,. Evidence-based development of liver allocation: a review. Transpl Int 2011; 24: 965-972.
22. Dawwas MF, Gimson AE,. Candidate selection and organ allocation in liver transplantation. Semin Liver Dis 2009; 29: 40-52.
23. Petrini C,. Kidney allocation for transplantation: some aspects of ethics and comparative law. Transplant Proc 2012; 44: 1812-1814.
24. Reese PP, Caplan AL,. Better off living-the ethics of the new UNOS proposal for allocating kidneys for transplantation. Clin J Am Soc Nephrol 2011; 6: 2310-2312.
25. Kerstein SJ, Bognar G,. Complete lives in the balance. Am J Bioeth 2010; 10: 37-45.
26. Kluge EH,. Drawing the ethical line between organ transplantation and lifestyle abuse. CMAJ 1994; 150: 745-746.
27. Persad G, Wertheimer A, Emanuel EJ,. Principles for allocation of scarce medical interventions. Lancet 2009; 373: 423-431.
28. Thornton V,. Who gets the liver transplant? The use of responsibility as the tie breaker. J Med Ethics 2009; 35: 739-742.
29. Center for Bioethics. Ethics of organ transplantation. http://www.ahc.umn.edu/img/assets/26104/Organ-Transplanta tion.pdf. Published February 2004. Accessed October 2013.
30. Jonsen AR, Siegler M, Winslade WJ,. Clinical Ethics: A Practical Approach to Ethical Decisions in Clinical Medicine. 7th ed. New York, NY: McGraw-Hill Medical; 2010.
31. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006; 6 (pt 2): 1212-1227.
32. Cherkassky L,. Does the United States do it better? A comparative analysis of liver allocation protocols in the United Kingdom and the United States. Camb Q Healthc Ethics 2011; 20: 418-433.
33. Emanuel EJ,. Justice and managed care. Four principles for the just allocation of health care resources. Hastings Cent Rep 2000; 30: 8-16.
34. Quante M, Benckert C, Thelen A, Jonas S,. Experience since MELD implementation: how does the new system deliver? Int J Hepatol 2012; 2012: 264015.
35. Strech D, Synofzik M, Marckmann G,. How physicians allocate scarce resources at the bedside: a systematic review of qualitative studies. J Med Philos 2008; 33: 80-99.
36. Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW,. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One 2013; 8: e51926.
37. Israni AK, Xiong H, Liu J, Salkowski N, Trotter JF, Snyder JJ, Kasiske BL,. Predicting end-stage renal disease after liver transplant. Am J Transplant 2013; 13: 1782-1792.
38. Kim WR, Kremers WK,. Benefits of the benefit model in liver transplantation. Hepatology 2008; 48: 697-698.
39. Kozower BD, Meyers BF, Smith MA, De Oliveira NC, Cassivi SD, Guthrie TJ, et al. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg 2008; 135: 166-171.
40. Ladin K, Hanto DW,. Rational rationing or discrimination: balancing equity and efficiency considerations in kidney allocation. Am J Transplant 2011; 11: 2317-2321.
41. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al.; for United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
42. Sharma P, Schaubel DE, Guidinger MK, Merion RM,. Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl 2009; 15: 1808-1813.
43. Getzen T,. Health Economics and Financing. 4th ed. Hoboken, NJ: John Wiley & Sons; 2010.
44. Ross LF, Thistlethwaite JR Jr,. Age should not be considered in the allocation of deceased donor kidneys. Semin Dial 2012; 25: 675-681.
45. Daniels N,. Just Health: Meeting Health Needs Fairly. Cambridge, United Kingdom: Cambridge University Press; 2008.
46. Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM,. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007; 7: 990-997.
47. Freeman RB Jr,. Survival benefit: quality versus quantity and trade-offs in developing new renal allocation systems. Am J Transplant 2007; 7: 1043-1046.